These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 9779292)
1. Myoid cells and neuroendocrine markers in myasthenic thymuses. Zółtowska A; Pawełczyk T; Stopa M; Skokowski J; Stepiński J; Roszkiewicz A; Nyka W Arch Immunol Ther Exp (Warsz); 1998; 46(4):253-7. PubMed ID: 9779292 [TBL] [Abstract][Full Text] [Related]
2. Epithelial-mesenchymal cell interactions and participation of the neuroendocrine markers in tumor development. Immunohistochemical study. Zółtowska A; Stepiński J; Kuczkowski J; Kamiński M; Cynowska B; Kruszewski W Arch Immunol Ther Exp (Warsz); 1998; 46(4):247-51. PubMed ID: 9779291 [TBL] [Abstract][Full Text] [Related]
3. Myoid and epithelial cell differentiation in myasthenic thymuses. Zółtowska A Thymus; 1991 Jun; 17(4):237-48. PubMed ID: 1714105 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical comparative investigations of lymphatic tissue in reactive processes, myasthenic thymuses and Hodgkin's disease. Zółtowska A Arch Immunol Ther Exp (Warsz); 1995; 43(1):15-22. PubMed ID: 8744679 [TBL] [Abstract][Full Text] [Related]
5. Fas and nicotinic acetylcholine receptor in human myasthenic thymus--immunohistochemical study. Kawanami S; Mori S; Kikuchi M; Shirakusa T Fukuoka Igaku Zasshi; 1999 Jun; 90(6):286-94. PubMed ID: 10423925 [TBL] [Abstract][Full Text] [Related]
6. Modulation of ABH histo-blood group antigen expression in normal and myasthenic human thymus. Sarafian VS; Marinova TT APMIS; 2006 Oct; 114(10):669-74. PubMed ID: 17004969 [TBL] [Abstract][Full Text] [Related]
7. Demonstration of phenotypic abnormalities of thymic epithelium in thymoma including two cases with abundant Langerhans cells. Kraus VB; Harden EA; Wittels B; Moore JO; Haynes BF Am J Pathol; 1988 Sep; 132(3):552-62. PubMed ID: 3261946 [TBL] [Abstract][Full Text] [Related]
8. Immunopathological study related to myoglobin in myasthenic and non-myasthenic thymuses. Koeda T Acta Pathol Jpn; 1986 Feb; 36(2):209-23. PubMed ID: 3518335 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical evidence for the expression of the carcinoembryonic antigen by human thymic epithelial cells in vitro and in neoplastic conditions. Savino W; Durand D; Dardenne M Am J Pathol; 1985 Dec; 121(3):418-25. PubMed ID: 3907364 [TBL] [Abstract][Full Text] [Related]
10. Acetylcholine receptor alpha-subunit and myogenin mRNAs in thymus and thymomas. Kornstein MJ; Asher O; Fuchs S Am J Pathol; 1995 Jun; 146(6):1320-4. PubMed ID: 7778671 [TBL] [Abstract][Full Text] [Related]
11. Increased number of Hassall's corpuscles in myasthenia gravis patients with thymic hyperplasia. Matsui N; Ohigashi I; Tanaka K; Sakata M; Furukawa T; Nakagawa Y; Kondo K; Kitagawa T; Yamashita S; Nomura Y; Takahama Y; Kaji R J Neuroimmunol; 2014 Apr; 269(1-2):56-61. PubMed ID: 24556356 [TBL] [Abstract][Full Text] [Related]
12. Development of Hassall's bodies of the thymus in humans and other vertebrates (especially mammals) under physiological and pathological conditions: immunocytochemical, electronmicroscopic and in vitro observations. Bodey B; Kaiser HE In Vivo; 1997; 11(1):61-85. PubMed ID: 9067775 [TBL] [Abstract][Full Text] [Related]
13. Myoid cells in the human thymus and thymoma revealed by three different immunohistochemical markers for striated muscle. Sato T; Tamaoki N Acta Pathol Jpn; 1989 Aug; 39(8):509-19. PubMed ID: 2816366 [TBL] [Abstract][Full Text] [Related]
14. Corpuscular thymoma: entity or variant of organotypical thymomas WHO B2/B3? Laeng RH; Eimoto T; Kuo TT; Zettl A; Marx A; Moschopulos M; Tateyama H; Shimokawa K Pathol Res Pract; 2006; 202(10):697-704. PubMed ID: 16887284 [TBL] [Abstract][Full Text] [Related]
16. The first histological and immunohistochemical examination of thymus in a case of fetus in fetu. Varga I; Jablonska V; Cingel V; Kubikova E; Dorko F; Polak S Ann Anat; 2010 Aug; 192(4):232-6. PubMed ID: 20634048 [TBL] [Abstract][Full Text] [Related]
17. [Relationship between expression of Cat V and clinicopathologic character of myasthenia gravis in patients with thymoma]. Wang Y; Huang Y; Luo DY; Yuan O; Gong RR; Qiu GD Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Nov; 37(6):886-8. PubMed ID: 17236586 [TBL] [Abstract][Full Text] [Related]
18. Phenotypic changes of the subseptal thymic epithelium in myasthenia gravis. Savino W; Takacs L; Monostori E; Dardenne M Thymus; 1988-1989; 12(2):111-6. PubMed ID: 2471300 [TBL] [Abstract][Full Text] [Related]
19. Autoimmunizing mechanisms in thymoma and thymus. Willcox N; Leite MI; Kadota Y; Jones M; Meager A; Subrahmanyam P; Dasgupta B; Morgan BP; Vincent A Ann N Y Acad Sci; 2008; 1132():163-73. PubMed ID: 18567866 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of vascular endothelial growth factor A (VEGF), and its receptors (VEGFR1, 2) in normal and pathologic conditions of the human thymus. Cimpean AM; Raica M; Encica S; Cornea R; Bocan V Ann Anat; 2008; 190(3):238-45. PubMed ID: 18356031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]